Recipient Name Nathan J. Fleck, Pharm.D., Northland Nuclear Medicine, LLC, 1815 Michigan Ave. Bismarck , ND 58504-6121 United States, (b)(4)FEI 3005334016Issued Oct 22, 2026Center for Drug Evaluation and Research (CDER)
Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy. To check it, open FDA's record for this establishment, listed under FEI 3005334016.
Violations2
Issue DateOct 22, 2026
Product TypeDrugs
StatusOpen
Letter Details
Firm
Northland Nuclear Medicine, LLC
Location
Recipient Name Nathan J. Fleck, Pharm.D., Northland Nuclear Medicine, LLC, 1815 Michigan Ave. Bismarck , ND 58504-6121 United States, (b)(4)
FEI Number
3005334016
Country
United States
Issue Date
October 22, 2026
Issuing Office
Center for Drug Evaluation and Research (CDER)
Product Type
Drugs
Status
Open
Subject
CGMP/Finished Pharmaceuticals/Adulterated
Northland Nuclear Medicine, LLC FDA Warning Letter, October 22, 2026
Talk to a Specialist